期刊文献+

复发性心房颤动的药物防治 被引量:1

下载PDF
导出
摘要 心房颤动治疗的目标是将心房颤动转复为窦性心律,控制心室率在100次/min以下,预防心房颤动复发,预防血栓形成和栓塞并发症。房颤的复律和预防复发是当前首要的房颤治疗策略。房颤转复为窦性心律是短期内的治疗目标,长期的目标是维持窦律。由于药物口服方便,不需要特殊的设备和技术条件,药物防治房颤复发仍是目前主要方法。
作者 田利
出处 《中国医药指南》 2013年第33期572-573,共2页 Guide of China Medicine
  • 相关文献

参考文献10

  • 1李庚山,吴宁,胡大一,黄从新,蒋文平,蔡乃绳.关于心房颤动病人治疗的建议[J].中国心脏起搏与心电生理杂志,2002,16(3):162-173. 被引量:96
  • 2胡大一.心血管疾病防治中国中国专家共识[J].北京:人民卫生出版社,2006:120-143.
  • 3Manios EG,Mavrakis HE,Kanoupakis EM,et al.Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence:a randomized controlled study[J].Cardiovasc Drugs Ther,2003,17(1):31-39.
  • 4Pratt CM,Singh SN,Al-Khalidi HR,et al.The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction[J].J Am Coll Cardiol,2004,43(7):1211-1216.
  • 5Li D,Shinagawa K,Pang L,et al.Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J].Circulation,2001,104(21):2608-2614.
  • 6Pedersen OD,Bagger H,Kober L,et al.Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
  • 7Vermes E,Tardif JC,Bourassa MG,et al.Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction:insight from the Studies Of Left ventricular Dysfunction(SOLVD)trials[J].Circulation,2003,107(23):2926-2931.
  • 8Madrid AH,Bueno MG,Rebollo JMG,et al.Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomized study[J].Circulati on,2002,106(3):331-336.
  • 9Wachtell K,Lehto M,Gerdts E,et al.AngiotensinⅡreceptor blockade reduces new-Onset atrial fibrillation and subsequent stroke compared to atenolol:AngiotensinⅡreceptor blockade reduces new-Onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension(LIFE)study[J].J Am Coll Cardiol,2005,45(5):712-719.
  • 10Yamagishi S.Role of insulin-sensitizing property of telmisartan,a commercially available angiotensinⅡtypeⅠreceptor blocker in preventing the development of atrial fibrillation[J].Med Hypotheses,2006,66(1):118-120.

共引文献95

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部